Evidence map›Paper›PMID 39597754›Full record

ArticleMicroorganisms2024

Recombinant SAG2A Protein from

Thaíse Anne Rocha Dos Santos, Mário Cézar de Oliveira, Edson Mario de Andrade Silva, Uener Ribeiro Dos Santos, Monaliza Macêdo Ferreira, Ana Luísa Corrêa Soares, Neide Maria Silva, Tiago Antônio de Oliveira Mendes, Jamilly Azevedo Leal-Sena, Jair Pereira da Cunha-Júnior and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Thaíse Anne Rocha Dos SantosCentro de Biotecnologia e Genética, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, BA, Brazil.
Mário Cézar de OliveiraInstituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia 38408-100, MG, Brazil.ORCID 0000-0002-0678-6011
Edson Mario de Andrade SilvaDepartamento de Bioquímica e Biologia Molecular, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.
Uener Ribeiro Dos SantosLaboratório de Imunobiologia, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, BA, Brazil.ORCID 0000-0003-1193-5453
Monaliza Macêdo FerreiraCentro de Biotecnologia e Genética, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, BA, Brazil.ORCID 0000-0002-4271-3602
Ana Luísa Corrêa SoaresLaboratory of Tropical Crop Improvement, Division of Crop Biotechnics, KU Leuven, 3000 Leuven, Belgium.
Neide Maria SilvaInstituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia 38408-100, MG, Brazil.ORCID 0000-0002-3615-1340
Tiago Antônio de Oliveira MendesDepartamento de Bioquímica e Biologia Molecular, Universidade Federal de Viçosa, Viçosa 36570-900, MG, Brazil.ORCID 0000-0002-5569-4893
Jamilly Azevedo Leal-SenaCentro de Biotecnologia e Genética, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, BA, Brazil.
Jair Pereira da Cunha-JúniorInstituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia 38408-100, MG, Brazil.
Tiago Wilson Patriarca MineoInstituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia 38408-100, MG, Brazil.
José Roberto MineoInstituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia 38408-100, MG, Brazil.ORCID 0000-0002-9010-7228
Érica Araújo MendesDepartamento de Microbiologia, Universidade de São Paulo, São Paulo 05508-000, SP, Brazil.
Jane Lima-SantosLaboratório de Imunobiologia, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, BA, Brazil.
Carlos Priminho PirovaniCentro de Biotecnologia e Genética, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, BA, Brazil.ORCID 0000-0002-6176-4069

Funding

Conselho Nacional de Pesquisa Científica e Tecnológica (CNPq) Process 303765/2019-4Coordenação de Aperfeicoamento de Pessoal de Nível Superior process No 0001
6 · The paper itself

Abstract

Toxoplasmosis is a neglected disease that represents a significant public health problem. The antigenic profile of

Indexed as

cytokineinflammationmacrophagesrSAG2AToxoplasma gondii

Identifiers

PMID39597754
PMCPMC11596811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.